drugset / Trial / NCT01631071
Re-licensing Study to Assess Virosomal Influenza Vaccine Formulated With WHO Recommended Influenza Strains
RandomizedParallel-groupOpen-labelPrevention
Summary
The study is to assess whether the virosomal influenza vaccine for season 2012/2013 fulfills the EMA requirements for re-registration of influenza vaccines.
Timeline
- Start
- 2012-07
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Inflexal V | Vaccine | 0.5 ml | Intramuscular |